The biological significance of histone modifiers in multiple myeloma: clinical applications (vol 11, 165, 2021)

被引：1
|
作者：
Ohguchi, Hiroto
Hideshima, Teru
Anderson, Kenneth C.
机构：
[1] Harvard Medical School,Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana
[2] Kumamoto University,Farber Cancer Institute
来源：
BLOOD CANCER JOURNAL | 2021年 / 11卷 / 10期
关键词：
D O I：
10.1038/s41408-021-00559-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The biological significance of histone modifiers in multiple myeloma: clinical applications
    Hiroto Ohguchi
    Teru Hideshima
    Kenneth C. Anderson
    Blood Cancer Journal, 8
  • [2] The biological significance of histone modifiers in multiple myeloma: clinical applications
    Ohguchi, Hiroto
    Hideshima, Teru
    Anderson, Kenneth C.
    BLOOD CANCER JOURNAL, 2018, 8
  • [3] Author Correction: The biological significance of histone modifiers in multiple myeloma: clinical applications
    Hiroto Ohguchi
    Teru Hideshima
    Kenneth C. Anderson
    Blood Cancer Journal, 11
  • [4] Clinical and biological significance of RAS mutations in multiple myeloma
    W J Chng
    N Gonzalez-Paz
    T Price-Troska
    S Jacobus
    S V Rajkumar
    M M Oken
    R A Kyle
    K J Henderson
    S Van Wier
    P Greipp
    B Van Ness
    R Fonseca
    Leukemia, 2008, 22 : 2280 - 2284
  • [5] Clinical and biological significance of RAS mutations in multiple myeloma
    Chng, W. J.
    Gonzalez-Paz, N.
    Price-Troska, T.
    Jacobus, S.
    Rajkumar, S. V.
    Oken, M. M.
    Kyle, R. A.
    Henderson, K. J.
    Van Wier, S.
    Greipp, P.
    Van Ness, B.
    Fonseca, R.
    LEUKEMIA, 2008, 22 (12) : 2280 - 2284
  • [6] Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
    Tandon, Nidhi
    Ramakrishnan, Vijay
    Kumar, Shaji K.
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2016, 8 : 35 - 44
  • [7] Transcriptional signature of histone deacetylase inhibition in multiple myeloma: Biological and clinical implications
    Mitsiades, CS
    Mitsiades, NS
    McMullan, CJ
    Poulaki, V
    Shringarpure, R
    Hideshima, T
    Akiyama, M
    Chauhan, D
    Munshi, N
    Gu, XS
    Bailey, C
    Joseph, M
    Libermann, TA
    Richon, VM
    Marks, PA
    Anderson, KC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (02) : 540 - 545
  • [8] Defining the Differentiation Stage of Multiple Myeloma Plasma Cells: Biological and Clinical Significance
    Paiva, Bruno
    Puig, Noemi
    Vidriales, Maria-Belen
    Carmen Gutierrez, Norma
    Hernandez, Miguel T.
    Rosinol, Laura
    Ocio, Enrique M.
    Oriol, Albert
    Asuncion Echeveste, Mara
    Gonzalez, Yolanda
    Gironella, Mercedes
    Prieto, Julio
    Jose Moreno, Maria
    Giraldo, Pilar
    Palomera, Luis
    Aoiz, Intza
    Blade, Joan
    Jose Lahuerta, Juan
    Mateos, Maria-Victoria
    San Miguel, Jesus F.
    BLOOD, 2014, 124 (21)
  • [9] CLINICAL-BIOLOGICAL SIGNIFICANCE OF DYSPLASTIC HEMATOPOIESIS IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
    Maia, Catarina
    Puig, Noemi
    Cedena, Maria-Teresa
    Goicoechea, Ibai
    Chillon, Maria-Carmen
    Gonzalez, Marcos
    Gutierrez, Norma C.
    Martinez-Lopez, Joaquin
    Orfao, Alberto
    Oriol, Albert
    De Arriba, Felipe
    Hernandez, Miguel T.
    Palomera, Luis
    Martinez, Rafael
    Rosinol, Laura
    Mateos, Maria-Victoria
    Lahuerta, Juan Jose
    Blade, Joan
    San Miguel, Jesus F.
    Paiva, Bruno
    HAEMATOLOGICA, 2020, 105 : 4 - 4
  • [10] The Biological Function and Clinical Significance of miR-886-5p in Multiple Myeloma
    Xiang, Pu
    Liu, Yuzhang
    Liu, Lina
    Lin, Quande
    Liu, Xiyang
    Zhang, Hongmei
    Xu, Jie
    Fang, Baijun
    ACTA HAEMATOLOGICA, 2019, 142 (04) : 208 - 216
12345